Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
BioLife Solutions, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $240.02M | $235.39M - $242.88M | -$87.12M | $1.79 | 1 |
| Dec 2029 | $199.75M | $195.90M - $202.13M | -$72.51M | $1.29 | 1 |
| Dec 2028 | $165.42M | $164.90M - $165.95M | -$60.05M | $0.85 | 2 |
| Dec 2027 | $134.08M | $130.76M - $135.79M | -$48.67M | $0.324 | 7 |
| Dec 2026 | $113.74M | $112.81M - $114.32M | -$41.29M | $0.143 | 7 |
| Dec 2025 | $96.12M | $95.58M - $96.58M | -$34.89M | -$0.337 | 6 |
| Dec 2024 | $104.59M | $80.86M - $113.10M | -$37.97M | -$0.466 | 5 |
| Dec 2023 | $139.96M | $137.26M - $141.63M | -$50.80M | -$1.413 | 2 |
| Dec 2022 | $160.90M | $160.25M - $161.56M | -$36.95M | -$2.253 | 2 |
| Dec 2021 | $117.66M | $114.52M - $121.74M | -$31.61M | -$0.013 | 3 |
| Dec 2020 | $46.92M | $45.67M - $48.55M | -$13.20M | $0.11 | 3 |
| Dec 2019 | $28.10M | $27.35M - $29.07M | -$7.90M | $0.401 | 2 |